Clinical evaluation of pediatric patients with recurrent respiratory papillomatosis.

Nasser Almutairi,Alanoud Alshathri,Waleed Alshareef,Abdullah Sindi,Abdullah Aljasser,Ahmed Alammar
DOI: https://doi.org/10.15537/smj.2024.45.2.20230529
2024-02-01
Saudi Medical Journal
Abstract:OBJECTIVES: To study the clinical evaluation of recurrent respiratory papillomatosis (RRP) patients and the factors associated with the improvement in the Derkay's score as a measure of disease severity.METHODS: A retrospective cohort that included all juvenile RRP patients who were admitted to King Abdulaziz University Hospital, Riyadh, Saudi Arabia, between September 2015 and June 2022 and underwent surgical debulking.RESULTS: A total of 16 patients were eligible to join our study. Among them, 7 patients were males. Hoarseness of voice was the most frequent symptom. The median period of the follow-up was 56 months. Complete remission was achieved in 31.3%. The univariate linear regression model revealed that the cidofovir-treated patients had a significant reduction in the change value of Derkay's score compared to those without treatment (regression coefficient= -5.83, 95% confidence interval [CI]: [-11.5 to -0.143], <i>p</i>=0.045). Also, the increased first Derkay's score decreased the change value and subsequently increased the improvement chance of the disease (regression coefficient= -0.424, 95% CI: [-0.764 to -0.083], <i>p</i>=0.018). However, in the multivariate regression model, both variables showed non-significant results.CONCLUSION: cidofovir treatment and higher Derkay's scores affected the disease improvement.
medicine, general & internal
What problem does this paper attempt to address?